Irinotecan in Treating Asian Patients With Solid Tumors
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as irinotecan, work in different ways to stop the
growth of tumor cells, either by killing the cells or by stopping them from dividing.
PURPOSE: This phase I trial is studying the side effects and best dose of irinotecan in
treating Asian patients with solid tumors.